Cargando…
Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients
PURPOSE: Liposomal bupivacaine demonstrated promise decreasing postoperative pain in total hip and total knee arthroplasty (THA/TKA). Some randomized trials have shown non-superior results; however, confounding variables were not accounted for in such analyses. This study attempts to determine risk...
Autores principales: | Buzin, Scott, Gianakos, Arianna L., Li, Deborah, Viola, Anthony, Elkattawy, Sherif, Keller, David M., Yoon, Richard S., Liporace, Frank A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990520/ https://www.ncbi.nlm.nih.gov/pubmed/32015758 http://dx.doi.org/10.1186/s13037-020-0230-4 |
Ejemplares similares
-
Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty
por: Gianakos, Arianna L., et al.
Publicado: (2021) -
Correction to: Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty
por: Gianakos, Arianna L., et al.
Publicado: (2022) -
Periarticular injection of liposomal bupivacaine in total knee arthroplasty
por: Webb, Bradley T., et al.
Publicado: (2015) -
Liposomal bupivacaine versus traditional bupivacaine for pain control after total hip arthroplasty: A meta-analysis
por: Ma, Ting-Ting, et al.
Publicado: (2017) -
Liposome bupivacaine for pain control after total knee arthroplasty: a meta-analysis
por: Wu, Zhong Qing, et al.
Publicado: (2016)